Stock Research for TGTX

TGTX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

TGTX Stock Chart & Research Data

The TGTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TGTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


TGTX Due diligence Resources & Stock Charts

The TGTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View TGTX Detailed Price Forecast - CNN Money CNN View TGTX Detailed Summary - Google Finance
Yahoo View TGTX Detailed Summary - Yahoo! Finance Zacks View TGTX Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View TGTX Trends & Analysis - Trade-Ideas Barrons View TGTX Major Holders - Barrons
NASDAQ View TGTX Call Transcripts - NASDAQ Seeking View TGTX Breaking News & Analysis - Seeking Alpha
Spotlight View TGTX Annual Report - CompanySpotlight.com OTC Report View TGTX OTC Short Report - OTCShortReport.com
TradeKing View TGTX Fundamentals - TradeKing Charts View TGTX SEC Filings - Bar Chart
WSJ View Historical Prices for TGTX - The WSJ Morningstar View Performance/Total Return for TGTX - Morningstar
MarketWatch View the Analyst Estimates for TGTX - MarketWatch CNBC View the Earnings History for TGTX - CNBC
StockMarketWatch View the TGTX Earnings - StockMarketWatch MacroAxis View TGTX Buy or Sell Recommendations - MacroAxis
Bullish View the TGTX Bullish Patterns - American Bulls Short Pains View TGTX Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View TGTX Stock Mentions - StockTwits PennyStocks View TGTX Stock Mentions - PennyStockTweets
Twitter View TGTX Stock Mentions - Twitter Invest Hub View TGTX Investment Forum News - Investor Hub
Yahoo View TGTX Stock Mentions - Yahoo! Message Board Seeking Alpha View TGTX Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for TGTX - SECform4.com Insider Cow View Insider Transactions for TGTX - Insider Cow
CNBC View TGTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for TGTX - OTC Markets
Yahoo View Insider Transactions for TGTX - Yahoo! Finance NASDAQ View Institutional Holdings for TGTX - NASDAQ


Stock Charts

FinViz View TGTX Stock Insight & Charts - FinViz.com StockCharts View TGTX Investment Charts - StockCharts.com
BarChart View TGTX Stock Overview & Charts - BarChart Trading View View TGTX User Generated Charts - Trading View




Latest Financial News for TGTX


Is TG Therapeutics, Inc.'s (NASDAQ:TGTX) Recent Price Movement Underpinned By Its Weak Fundamentals?
Posted on Tuesday March 19, 2024

It is hard to get excited after looking at TG Therapeutics' (NASDAQ:TGTX) recent performance, when its stock has...


13 Best Biotech Stocks To Buy Under $20
Posted on Wednesday March 13, 2024

In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]


TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Posted on Friday March 08, 2024

NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data from the ULTIMATE I & II Phase 3 trials evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the upcoming American Academy of Neurology 2024 annual meeting, being held April 13 - 18, 2024, in Dever, Colorado. Abstracts are now available online and can be accessed on the AAN meeting website at htt


TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Posted on Friday March 01, 2024

NEW YORK, March 01, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial evaluating BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual forum, being held in West Palm Beach, Florida. Links to each presentation are included below. Michael S. Weiss,


Stock Market & Investing Books

Enter a stock symbol to view the stock details.